Study reveals hyperimmune intravenous immunoglobulin doesn't help COVID-19 patients
A new study has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than
Foster City United States National Institutes Of Health Comunidad Autonoma De Cataluna Australian Capital Territory Mark Polizzotto
Source: northernirelandnews.com